搜索临床试验以:3,4-methyelendioxymethamphetamine 25 mg
总计693个结果
-
Boehringer Ingelheim完全的
-
Chiesi Farmaceutici S.p.A.完全的
-
Massachusetts General HospitalGilead Sciences撤销
-
European Organisation for Research and Treatment...Breast International Group; Menarini Group招聘中
-
Aziende Chimiche Riunite Angelini Francesco S.p.AChiltern International Inc.完全的
-
Centre Hospitalier Universitaire de Saint Etienne完全的
-
All India Institute of Medical Sciences, New Delhi完全的
-
New York State Psychiatric InstituteWeill Medical College of Cornell University; University of Kansas Medical Center; Research Foundation... 和其他合作者尚未招聘
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of LouisvilleJames Graham Brown Cancer Center完全的
-
Janssen Research & Development, LLC完全的
-
Chinese Academy of Medical Sciences, Fuwai Hospital招聘中
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge Institute未知
-
Roswell Park Cancer InstituteUnited States Department of Defense招聘中临床 III 期胃食管结合部腺癌 AJCC v8 | 临床 IV 期胃食管结合部腺癌 AJCC v8 | 转移性胃食管结合部腺癌 | 不可切除的胃食管结合部腺癌 | 局部晚期胃食管结合部腺癌 | 临床 II 期食管腺癌 AJCC v8 | 临床 III 期食管腺癌 AJCC v8 | 临床 IV 期食管腺癌 AJCC v8 | 转移性食管腺癌 | 不可切除的食管腺癌 | 局部晚期食管腺癌美国
-
Sidney Kimmel Cancer Center at Thomas Jefferson...完全的
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人弥漫性大 B 细胞淋巴瘤 | 惰性非霍奇金淋巴瘤 | Ann Arbor II 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor III 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor IV 期弥漫性大 B 细胞淋巴瘤 | 具有 MYC 和 BCL2 或 BCL6 重排的高级别 B 细胞淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的高级别 B 细胞淋巴瘤 | Ann Arbor II 期滤泡性淋巴瘤 | Ann Arbor III 期滤泡性淋巴瘤 | Ann Arbor IV 期滤泡性淋巴瘤 | 具有 MYC 和 BCL2 和/或 BCL6 重排的高级别 B 细胞淋巴瘤 | Ann Arbor II 期边缘区淋巴瘤 | Ann Arbor... 及其他条件美国